MD · Pediatrix Medical Group, Inc.
$26.61
+0.24 (+0.91%)
At close · Aug 14
Market Cap
$2.16B
Shares
81.25M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-13 | Weis Shirley A | Director | 36,028 | 2026-05-13 | Robert W. Baird & Co. |
| 2025-12-15 | ORDAN MARK S | Director | 23,000 | 2025-12-15 | Piper Sandler & Co Inc |
| 2025-11-17 | Rucker Michael A. | Director | 10,478 | 2025-11-17 | Robert W. Baird |
| 2025-11-06 | Laura A Linynsky | Director | 10,000 | 2025-11-06 | Merrill Lynch |
| 2025-02-21 | Swift James D | Former Officer | 18,530 | 2025-02-21 | Merrill Lynch |
| 2024-11-13 | ORDAN MARK S | Director | 27,600 | 2024-11-13 | Piper Sandler & Co Inc |
| 2024-11-08 | Moore Mary Ann E | Officer | 8,108 | 2024-11-08 | Merrill Lynch |
| 2024-11-04 | Richards C Marc | Former Officer | 118,291 | 2024-11-04 | Merrill Lynch |
| 2024-08-30 | Swift James D | Officer | 11,100 | 2024-08-30 | Merrill Lynch |
| 2024-08-27 | Linynsky Laura A | Director | 7,000 | 2024-08-27 | Merrill Lynch |
| 2024-08-09 | Richards C Marc | Officer | 50,000 | 2024-08-09 | Merrill Lynch |
| 2024-08-09 | Wood Lee | Former Officer | 47,230 | 2024-08-09 | Merrill Lynch |
| 2023-12-14 | Swift James D | Officer | 5,764 | 2023-12-14 | Merrill Lynch |
| 2023-06-14 | Swift James D | Officer | 13,193 | 2023-06-14 | Merrill Lynch |
| 2023-05-24 | ORDAN MARK S | Director | 33,000 | 2023-05-24 | Piper Sandler & Co. |
| 2023-05-19 | Weis Shirley A | Director | 1,007 | 2023-05-19 | Robert W. Baird & Co. |
| 2023-05-18 | Weis Shirley A | Director | 17,993 | 2023-05-18 | Merrill Lynch |
| 2023-05-12 | Roger J. Medel | Affiliate | 227,734 | 2023-05-12 | UBS Financial Services Inc |
| 2023-05-10 | Roger J. Medel. M.D. | Affiliate | 50,000 | 2023-05-10 | UBS Financial Services Inc |
Showing 1–19 of 19 filings
Key facts
CIK
893949
CUSIP
58502B106
13F (30d)
283 filings
282 filers
Visit website
Investor relations